Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease

被引:73
作者
Ajmera, Veeral H. [1 ,2 ]
Liu, Amy [1 ]
Singh, Seema [1 ]
Yachoa, Georg [1 ]
Ramey, Matthew [1 ]
Bhargava, Meera [1 ]
Zamani, Ava [1 ]
Lopez, Scarlett [1 ]
Mangla, Neeraj [1 ]
Bettencourt, Ricki [1 ]
Rizo, Emily [1 ]
Valasek, Mark [3 ]
Behling, Cynthia [4 ]
Richards, Lisa [1 ]
Sirlin, Claude [5 ]
Loomba, Rohit [1 ,2 ]
机构
[1] Univ Calif San Diego, NAFLD Res Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[4] Sharp Med Grp, Dept Pathol, San Diego, CA USA
[5] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, La Jolla, CA 92093 USA
关键词
TRANSIENT ELASTOGRAPHY; NONINVASIVE DIAGNOSIS; SAMPLING VARIABILITY; HEPATIC STEATOSIS; WEIGHT-LOSS; NAFLD; STEATOHEPATITIS; ACCURATE; BIOPSY; MRI;
D O I
10.1002/hep.30974
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Cross-sectional studies have shown that magnetic resonance elastography (MRE) is accurate in the noninvasive detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD). However, there are limited data on the longitudinal association between an increase in liver stiffness on MRE and fibrosis progression in NAFLD. Therefore, using a well-characterized prospective cohort of patients with biopsy-proven NAFLD, we aimed to examine the longitudinal association between a 15% increase in liver stiffness on MRE and fibrosis progression in NAFLD. Approach and Results This prospective cohort study included 102 patients (62.7% women) with biopsy-proven NAFLD who underwent contemporaneous MRE and liver biopsy at baseline followed by a repeat paired liver biopsy and MRE assessment. The primary outcome was odds of fibrosis progression by one or more stage as assessed by the Nonalcoholic Steatohepatitis Clinical Research Network histologic scoring system. The mean (+/- SD) of age and body mass index (BMI) were 52 (+/- 14) years and 32.6 (+/- 5.3) kg/m(2), respectively. The median time interval between the two paired assessments was 1.4 years (interquartile range 2.15 years). The number of patients with fibrosis stages 0, 1, 2, 3, and 4 was 27, 36, 12, 17, and 10, respectively. In unadjusted analysis, a 15% increase in MRE was associated with increased odds of histologic fibrosis progression (odds ratio [OR], 3.56; 95% confidence interval [CI], 1.17-10.76; P = 0.0248). These findings remained clinically and statistically significant even after multivariable adjustment for age, sex, and BMI (adjusted OR, 3.36; 95% CI, 1.10-10.31; P = 0.0339). A 15% increase in MRE was the strongest predictor of progression to advanced fibrosis (OR, 4.90; 95% CI, 1.35-17.84; P = 0.0159). Conclusions A 15% increase in liver stiffness on MRE may be associated with histologic fibrosis progression and progression from early fibrosis to advanced fibrosis.
引用
收藏
页码:849 / 860
页数:12
相关论文
共 42 条
[1]   Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[2]   Sampling variability of liver fibrosis in chronic hepatitis C [J].
Bedossa, P ;
Dargère, D ;
Paradis, V .
HEPATOLOGY, 2003, 38 (06) :1449-1457
[3]   Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease [J].
Castera, Laurent ;
Friedrich-Rust, Mireen ;
Loomba, Rohit .
GASTROENTEROLOGY, 2019, 156 (05) :1264-+
[4]   Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis [J].
Chalasani, Naga ;
Abdelmalek, Manal F. ;
Loomba, Rohit ;
Kowdley, Kris, V ;
McCullough, Arthur J. ;
Dasarathy, Srinivasan ;
Neuschwander-Tetri, Brent A. ;
Terrault, Norah ;
Ferguson, Beatrice ;
Shringarpure, Reshma ;
Shapiro, David ;
Sanyal, Arun J. .
LIVER INTERNATIONAL, 2019, 39 (05) :924-932
[5]   Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE [J].
Doycheva, I. ;
Cui, J. ;
Nguyen, P. ;
Costa, E. A. ;
Hooker, J. ;
Hofflich, H. ;
Bettencourt, R. ;
Brouha, S. ;
Sirlin, C. B. ;
Loomba, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) :83-95
[6]   Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis [J].
Dulai, Parambir S. ;
Singh, Siddharth ;
Patel, Janki ;
Soni, Meera ;
Prokop, Larry J. ;
Younossi, Zobair ;
Sebastiani, Giada ;
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Stal, Per ;
Wong, Vincent Wai-Sun ;
Kechagias, Stergios ;
Hultcrantz, Rolf ;
Loomba, Rohit .
HEPATOLOGY, 2017, 65 (05) :1557-1565
[7]   Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up [J].
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Fredrikson, Mats ;
Stal, Per ;
Kechagias, Stergios ;
Hultcrantz, Rolf .
HEPATOLOGY, 2015, 61 (05) :1547-1554
[8]   Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease [J].
Estes, Chris ;
Razavi, Homie ;
Loomba, Rohit ;
Younossi, Zobair ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :123-133
[9]  
Harrison SA, 2017, HEPATOLOGY, V66, p1120A
[10]   T1 Independent, T2* Corrected Chemical Shift Based Fat-Water Separation With Multi-peak Fat Spectral Modeling Is an Accurate and Precise Measure of Hepatic Steatosis [J].
Hines, Catherine D. G. ;
Frydrychowicz, Alex ;
Hamilton, Gavin ;
Tudorascu, Dana L. ;
Vigen, Karl K. ;
Yu, Huanzhou ;
McKenzie, Charles A. ;
Sirlin, Claude B. ;
Brittain, Jean H. ;
Reeder, Scott B. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2011, 33 (04) :873-881